Novavax CEO: UK data should be used for quicker U.S. COVID-19 vaccine rollout

Novavax (NVAX) CEO Stanley Erck is hoping the U.S. Food and Drug Administration (FDA) will consider using the company’s U.K. data to speed up rollout of its COVID-19 vaccine, rather than waiting until later in March.